Arkolith/Insider Trading/IMPL/Form 4

Adams Adrian

COB, CEO and President, DirectorIMPEL NEUROPHARMA INC (IMPL) · full profile →Form 4 · filed Aug 19, 2021
Net Buying
Open-Market Buys
$280K
Open-Market Sells
$0
Net Open-Market Flow
$280K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 18, 2021Buy(P)17K$13.81$238K17K
Aug 18, 2021Buy(P)2K$14.91$33K19K
Aug 18, 2021Buy(P)600$15.89$10K20K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-052595) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML